Core Viewpoint - Verano Holdings Corporation (VRNO) has experienced a strong stock recovery, rising over 40% in the past year, significantly outperforming the cannabis industry due to renewed optimism around federal marijuana reform [1][3]. Group 1: Federal Marijuana Reform Impact - The stock rally is largely attributed to President Trump's favorable comments and executive order regarding the potential rescheduling of marijuana, which has positively influenced U.S.-listed cannabis stocks, including Verano [3][5]. - The executive order aims to expedite the reclassification of marijuana from Schedule I to Schedule III under the Controlled Substances Act, acknowledging its medical value and representing a significant regulatory shift for the cannabis industry [5][9]. - Rescheduling could improve long-term profitability for operators like Verano by eliminating IRS Code 280E, which currently inflates effective tax rates by preventing cannabis companies from deducting ordinary business expenses [6][9]. Group 2: Company Performance and Sales - In the first nine months of 2025, Verano's retail sales increased by 1% year-over-year to $502.4 million, primarily driven by product availability in Florida, while wholesale revenue fell by 13% to $234.9 million due to pricing pressures and accounts receivable strategies [7][11]. - Gross margin contracted by approximately 100 basis points to 50%, influenced by promotional activities and price compression, although SG&A expenses decreased by 7% to $251.5 million due to cost optimization efforts [12]. - Despite current challenges, Verano maintains an optimistic outlook for future quarters, focusing on operational efficiencies, retail expansion, and product innovation [13]. Group 3: Competitive Landscape - Verano operates in a highly competitive U.S. cannabis market, facing challenges from peers like Cresco Labs and Tilray Brands, which are also expanding and implementing cost-control measures [14]. - Competitors are gaining an edge through international expansion, while Verano remains focused solely on the U.S. market, which is becoming increasingly saturated [15]. Group 4: Earnings Estimates and Investor Sentiment - Loss estimates for Verano for 2025 and 2026 have widened over the past 60 days, indicating potential near-term risks [16]. - The company's focus on cost discipline and dispensary expansion is strengthening its operational foundation, but investors may prefer to wait for clearer signs before making investment decisions [17].